Alliance Pharma PLC has received a notification of major holdings from Royal Bank of Canada PH. The reason for the notification is an acquisition or disposal of voting rights. The shareholder is RBC Global Asset Management (UK) Limited. The threshold was crossed or reached on August 25, 2023, and the issuer was notified on August 28, 2023. The resulting situation on the date the threshold was crossed or reached is that RBC Global Asset Management holds 2.693040% of the voting rights in Alliance Pharma, with a total of 14,546,460 voting rights. This is a decrease from their previous position of 3.067000% of voting rights. The notification also includes information about the full chain of controlled undertakings through which the voting rights and/or financial instruments are effectively held, with Royal Bank of Canada being the ultimate controlling person. The notification does not provide any information about proxy voting or additional information. The completion date of the notification is August 28, 2023.